Riskpilot← Back to searchSign inGet full accessTetra Pharm Technologies ApS
APSActiveCVR 40738223Ørestads Boulevard 108Manufacture of pharmaceutical preparations · NACE 2120Est. 201947 employeeshttps://www.tetrapharm.eu/
Revenue 2024
DKK 1,5M
+150% vs 2023
EBITDA margin
-3909.8%
-47% vs 2023
Equity ratio
85.5%
Financial strength
Net profit 2024
DKK -55,2M
-68% vs 2023
| Revenue | DKK 1,5M | +150% |
| EBITDA | DKK -57,1M | -47% |
| Net profit | DKK -55,2M | -68% |
| Total assets | DKK 31,3M | -10% |
| Equity | DKK 26,7M | -17% |
| Employees | 47 | — |
Legal name
Tetra Pharm Technologies ApS
CVR number
40738223
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
26. august 2019
Share capital
DKK 67.595
Employees
47 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse i forening
Company purpose
Selskabets formål er at være biotekselskab, investering samt enhver beslægtet virksomhed efter ledelsens beslutning.
Address
Ørestads Boulevard 108
Phone
+4529737073
Email
jesper@tetrapharm.eu
Website
https://www.tetrapharm.eu/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -926 | 3.208 | -510 | 585 | 1.461 |
| Staff expenses | -146 | -3.535 | -10.324 | -18.752 | -28.426 |
| EBITDA | -1.072 | -327 | -10.835 | -38.817 | -57.108 |
| Depreciation & amort. | -73 | -88 | -99 | -0 | -3.898 |
| EBIT | -1.145 | -414 | -10.933 | -38.817 | -61.006 |
| Net financials | -6 | -88 | -58 | 416 | 140 |
| Profit before tax | -1.151 | -502 | -10.992 | -38.401 | -60.866 |
| Tax | -253 | -807 | -3.224 | -5.454 | -5.652 |
| Net profit | -898 | 306 | -7.768 | -32.947 | -55.214 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 912 | 18.288 | 85.332 | 34.580 | 31.278 |
| Equity | -856 | 13.787 | 79.924 | 32.088 | 26.745 |
| Long-term debt | 1.385 | 3.805 | 2.753 | 0 | 0 |
| Short-term debt | 383 | 0 | 868 | 2.492 | 4.532 |
| Total debt | 1.768 | 3.805 | 3.620 | 2.492 | 4.532 |
EBITDA margin
-3909.8%
This company
15.8%
Market median
-24846% vs market
20202024
Equity ratio
85.5%
This company
38.2%
Market median
+124% vs market
20202024
Return on equity
-206.4%
This company
18.4%
Market median
-1222% vs market
20202024
Net profit margin
-3780.1%
This company
8.1%
Market median
-46768% vs market
20202024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-26 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nesroht Holding ApS | Company | 20.0% | 20.0% | 2025 |
BrainFrame ApS | Company | 20.0% | 20.0% | 2025 |
Breum Holding EST. 2016 ApS | Company | 20.0% | 20.0% | 2025 |
RUMP INVEST ApS | Company | 5.0% | 5.0% | 2022 |
| Individual | 5.0% | 5.0% | 2022 | |
OLE GS HOLDING ApS | Company | 5.0% | 5.0% | 2022 |
| Individual | 10.0% | 10.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Breum Holding EST. 2016 ApS
Tetra Pharm Technologies ApS Board members of Tetra Pharm Technologies ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Stefan Rose | Management | 0 companies |
| Jesper Breum Kanchanarat | Chairman | 0 companies |
| Lars Frøvang Thomsen | Board of Directors | 0 companies |
| Søren Rose | Chairman | 0 companies |
| Per Mogens Bugge | Board of Directors | 0 companies |
| Nikolay Tretiyakov | Board of Directors | 0 companies |